Biofarm also forecasts its net profit down 10% in 2013, to RON19 million (EUR4.3 million), compared with RON21 million in 2012.
The costs with raw materials and consumables are expected to increase 5% in 2013, to almost RON33 million (EUR7.5 million), while the expenditures with staff may be up 14%, to RON19.3 million (EUR4.4 million), according to the budget of revenues and expenses to be discussed in stockholders meeting April 18.
In 2013, Biofarm scheduled investments of RON35.8 million (EUR8.1 million), up 20% from a year before. The most important investments should target the acquisition of production equipments, RON16.5 million, and the expansion of the production flow, RON10.3 million.
The company is owned by regional investment funds SIF Oltenia (SIF5.RO) – 26.97%, SIF Crisana-Banat (SIF1.RO) – 19.51%, SIF Moldova (SIF2.RO) – 12.56% and privatization authority AVAS – 1.05%.
On the Bucharest bourse Friday, Biofarm closed flat on the day, at RON0.24 a share. (EUR1=RON4.3940)